Search Results - "Mills, Matthew N"

Trastuzumab Emtansine (T-DM1) and stereotactic radiation in the management of HER2+ breast cancer brain metastases by Mills, Matthew N, Walker, Chelsea, Thawani, Chetna, Naz, Afrin, Figura, Nicholas B, Kushchayev, Sergiy, Etame, Arnold, Yu, Hsiang-Hsuan Michael, Robinson, Timothy J, Liu, James, Vogelbaum, Michael A, Forsyth, Peter A, Czerniecki, Brian J, Soliman, Hatem H, Han, Hyo S, Ahmed, Kamran A

“…Due to recent concerns about the toxicity of trastuzumab emtansine (T-DM1) with stereotactic radiation, we assessed our institutional outcomes treating…”
Get full text

Capecitabine and stereotactic radiation in the management of breast cancer brain metastases by Mills, Matthew N, Naz, Afrin, Thawani, Chetna, Walker, Chelsea, Figura, Nicholas B, Kushchayev, Sergiy, Oliver, Daniel E, Etame, Arnold B, Yu, Hsiang-Hsuan Michael, Robinson, Timothy J, Liu, James K C, Vogelbaum, Michael A, Forsyth, Peter A, Czerniecki, Brian J, Soliman, Hatem H, Han, Hyo S, Ahmed, Kamran A

“…Little is known about the safety and efficacy of concurrent capecitabine and stereotactic radiotherapy in the setting of breast cancer brain metastases (BCBM)…”
Get full text

Prediction of radiologic outcome-optimized dose plans and post-treatment magnetic resonance images: A proof-of-concept study in breast cancer brain metastases treated with stereotactic radiosurgery by Pandey, Shraddha, Kutuk, Tugce, Abdalah, Mahmoud A., Stringfield, Olya, Ravi, Harshan, Mills, Matthew N., Graham, Jasmine A., Latifi, Kujtim, Moreno, Wilfrido A., Ahmed, Kamran A., Raghunand, Natarajan

“…Information in multiparametric Magnetic Resonance (mpMR) images is relatable to voxel-level tumor response to Radiation Treatment (RT). We have investigated a…”
Get full text

Novel Definitive Hypofractionated Accelerated Radiation Dose-painting (HARD) for Unresected Soft Tissue Sarcomas by Bryant, John Michael, Mills, Matthew N., Yang, George Q., Liveringhouse, Casey, Palm, Russell, Johnstone, Peter A., Miller, Justin T., Latifi, Kujtim, Feygelman, Vladimir, Naghavi, Arash O.

“…Soft tissue sarcomas (STS) are historically radioresistant, with surgery being an integral component of their treatment. With their low α/β, STS may be more…”
Get full text

Multi-institutional report of trastuzumab deruxtecan and stereotactic radiosurgery for HER2 positive and HER2-low breast cancer brain metastases by Khatri, Vaseem M., Mestres-Villanueva, Mariella A., Yarlagadda, Sreenija, Doniparthi, Ajay, Smith, David B., Nakashima, Justyn Y., Bryant, John M., Zhao, Dekuang, Upadhyay, Rituraj, Mills, Matthew N., Oliver, Daniel E., Yu, Hsiang-Hsuan Michael, Palmer, Joshua D., Williams, Nicole O., Mahtani, Reshma L., Ahluwalia, Manmeet S., Soliman, Hatem H., Han, Hyo S., Soyano, Aixa E., Kim, Youngchul, Kotecha, Rupesh, Beyer, Sasha J., Ahmed, Kamran A.

“…Trastuzumab-deruxtecan (T-DXd) has demonstrated intracranial efficacy; however, safety and efficacy data remains limited with stereotactic radiosurgery (SRS)…”
Get full text

Miliary breast cancer brain metastasis: a rare and aggressive form of central nervous system metastasis by Mills, Matthew N., Ahmed, Kamran A.

“…Summary Although breast cancer brain metastasis is an increasingly common occurrence, relatively little is known about miliary brain metastases, a rare subtype…”
Get full text

Histologic heterogeneity of triple negative breast cancer: A National Cancer Centre Database analysis by Mills, Matthew N., Yang, George Q., Oliver, Daniel E., Liveringhouse, Casey L., Ahmed, Kamran A., Orman, Amber G., Laronga, Christine, Hoover, Susan J., Khakpour, Nazanin, Costa, Ricardo L.B., Diaz, Roberto

“…Triple negative breast cancer (TNBC) is an aggressive disease, but recent studies have identified heterogeneity in patient outcomes. However, the utility of…”
Get full text

Management of brain metastases in breast cancer: a review of current practices and emerging treatments by Mills, Matthew N., Figura, Nicholas B., Arrington, John A., Yu, Hsiang-Hsuan Michael, Etame, Arnold B., Vogelbaum, Michael A., Soliman, Hatem, Czerniecki, Brian J., Forsyth, Peter A., Han, Hyo S., Ahmed, Kamran A.

“…Purpose Breast cancer brain metastases (BCBM) are becoming an increasingly common diagnosis due to improved systemic control and more routine surveillance…”
Get full text

Neoadjuvant Simultaneous Integrated Boost Radiation Therapy Improves Clinical Outcomes for Retroperitoneal Sarcoma by Liveringhouse, Casey L, Palm, Russell F, Bryant, John M, Yang, George Q, Mills, Matthew N, Figura, Nicholas D, Ahmed, Kamran A, Mullinax, John, Gonzalez, Ricardo, Johnstone, Peter A, Naghavi, Arash O

“…Neoadjuvant radiation therapy (RT) with standard techniques (ST) offers a modest benefit in retroperitoneal sarcoma (RPS). As the high-risk region (HRR) at…”
Get full text

Hypofractionated accelerated radiation dose-painting (HARD) improves outcomes in unresected soft-tissue sarcoma by Bryant, John Michael, Mills, Matthew N., Liveringhouse, Casey, Palm, Russell, Druta, Mihaela, Brohl, Andrew, Reed, Damon R., Johnstone, Peter A., Miller, Justin T., Latifi, Kujtim, Feygelman, Vladimir, Yang, George Q., Naghavi, Arash O.

“…•The HARD regimen for unresected STS resulted in excellent local control.•HARD improved local control compared to standard fractionation.•HARD was safe and not…”
Get full text

Phase 2 Study of Preoperative SABR for Early-Stage Breast Cancer: Introduction of a Novel Form of Accelerated Partial Breast Radiation Therapy by Liveringhouse, Casey L., Mills, Matthew N., Ahmed, Kamran A., Washington, Iman R., Lee, Marie C., Khakpour, Nazanin, Laronga, Christine, Czerniecki, Brian, Soliman, Hatem, Weinfurtner, Robert J., Rosa, Marilin, Kim, Youngchul, Stringfield, Olya, Abdalah, Mahmoud, Diaz, Roberto, Montejo, Michael

Get full text

Evolving management of HER2+ breast cancer brain metastases and leptomeningeal disease by Mills, Matthew N., King, Whitney, Soyano, Aixa, Pina, Yolanda, Czerniecki, Brian J., Forsyth, Peter A., Soliman, Hatem, Han, Hyo S., Ahmed, Kamran A.

“…Patients with human epidermal growth factor receptor 2 (HER2)-positive breast cancer are at a particularly high risk of breast cancer brain metastasis (BCBM)…”
Get full text

Tucatinib and stereotactic radiosurgery in the management of HER2 positive breast cancer brain metastases by Khatri, Vaseem M., Mills, Matthew N., Oliver, Daniel E., Yu, Hsiang-Hsuan Michael, Vogelbaum, Michael A., Forsyth, Peter A., Soliman, Hatem H., Han, Hyo S., Ahmed, Kamran A.

“…Purpose HER2-positive breast cancer has a high risk of brain metastasis. Stereotactic radiosurgery (SRS) is standard of care for limited brain metastases…”
Get full text

Clinical outcomes of non-small cell lung cancer brain metastases treated with stereotactic radiosurgery and immune checkpoint inhibitors, EGFR tyrosine kinase inhibitors, chemotherapy and immune checkpoint inhibitors, or chemotherapy alone by Dohm, Ammoren E, Tang, Joseph D, Mills, Matthew N, Liveringhouse, Casey L, Sandoval, Maria L, Perez, Bradford A, Robinson, Timothy J, Creelan, Benjamin C, Gray, Jhanelle E, Etame, Arnold B, Vogelbaum, Michael A, Forsyth, Peter, Yu, Hsiang-Hsuan Michael, Oliver, Daniel E, Ahmed, Kamran A

“…Immune checkpoint inhibitors (ICIs) and epidermal growth factor receptor-tyrosine kinase inhibitors (EGFR-TKIs) are commonly used in the systemic management of…”
Get full text

Stereotactic Body Radiation Therapy in Oligometastatic Uterine Cancer: Clinical Outcomes and Toxicity by Reddy, Abhinav V., Mills, Matthew N., Reshko, Leonid B., Martin Richardson, K., Kersh, Charles R.

“…We report on clinical outcomes in patients with oligometastatic uterine cancer treated with stereotactic body radiation therapy (SBRT). Twenty-seven patients…”
Get full text

Increased Risk for Ipsilateral Breast Tumor Recurrence in Invasive Lobular Carcinoma after Accelerated Partial Breast Irradiation Brachytherapy by Mills, Matthew N., Russo, Nicholas W., Fahey, Matthew, Nanda, Ronica H., Raiker, Sunny, Jastrzebski, Jessica, Stout, Lisa L., Wilson, Jason P., Altoos, Taghrid A., Allen, Kathleen G., Blumencranz, Peter W., Diaz, Roberto

“…Background The suitability criteria for accelerated partial breast irradiation (APBI) from the American Brachytherapy Society (ABS), American Society for…”
Get full text

Clinical Outcomes of Patients with Non-Small Cell Lung Cancer Leptomeningeal Disease Following Receipt of EGFR-Targeted Therapy, Immune-Checkpoint Blockade, Intrathecal Chemotherapy, or Radiation Therapy Alone by Mills, Matthew N., Uno, Akihiro, Li, Pinxue, Liveringhouse, Casey, Kim, Youngchul, Oliver, Daniel E., Perez, Bradford A., Creelan, Benjamin C., Yu, Michael, Forsyth, Peter A., Pina, Yolanda, Ahmed, Kamran A.

“…•Patients with NSCLC LMD have a poor prognosis, with a 6-month OS of 35%.•EGFR-positive NSCLC LMD who received targeted therapy have improved OS.•EGFR-positive…”
Get full text

Clinical outcomes of melanoma brain metastases treated with nivolumab and ipilimumab alone versus nivolumab and ipilimumab with stereotactic radiosurgery by Tang, Joseph D., Mills, Matthew N., Nakashima, Justyn, Dohm, Ammoren E., Khushalani, Nikhil I., Forsyth, Peter A., Vogelbaum, Michael A., Wuthrick, Evan J., Yu, Hsiang-Hsuan M., Oliver, Daniel E., Liu, James K. C., Ahmed, Kamran A.

“…Purpose Upfront dual checkpoint blockade with immune checkpoint inhibitors (ICI) has demonstrated efficacy for treating melanoma brain metastases (MBM) in…”
Get full text

The Prognostic Role of Pretreatment Neutrophil to Lymphocyte Ratio (NLR) in Malignant Adrenal Lesions Treated With Stereotactic Body Radiation Therapy (SBRT) by Mills, Matthew N, Reddy, Abhinav V, Richardson, Logan, Richardson, K Martin, Kersh, Charles R

“…The objective of this study was to evaluate a single institution's experience with stereotactic body radiotherapy (SBRT) in treating malignant adrenal lesions,…”
Get full text

The presentation of brain metastases in melanoma, non-small cell lung cancer, and breast cancer and potential implications for screening brain MRIs by Mills, Matthew N., Potluri, Thrisha K., Kawahara, Yuki, Fahey, Matthew, Figura, Nicholas B., Soyano, Aixa E., Washington, Iman R., Diaz, Roberto, Oliver, Daniel E., Yu, Hsiang-Hsuan Michael, Etame, Arnold B., Vogelbaum, Michael A., Czerniecki, Brian J., Arrington, John A., Sahebjam, Solmaz, Forsyth, Peter A., Soliman, Hatem H., Han, Hyo S., Ahmed, Kamran A.

“…Purpose This study assessed the presentation and institutional outcomes treating brain metastases (BM) of breast cancer (BC), non-small cell lung cancer…”
Get full text